FDA 21 CFR Part 820 (QSR) Consultant in Delhi
The medical device industry in Delhi is rapidly growing, with a significant presence of domestic and international players. In subject to the regulatory requirements of 21 CFR Part 820, which establishes quality system regulations for medical device manufacturers. Compliance with these regulations is crucial for companies to ensure the safety and efficacy of their products and meet the necessary standards for FDA approval.
With the help of Operon Strategistas a experienced FDA consultants in Delhi, medical device companies can navigate these regulations and implement effective quality management systems to ensure that their products meet all necessary safety and efficacy requirements.
What is FDA 21 CFR Part 820?
21 CFR Part 820, also known as the Quality System Regulation (QSR), is a set of regulations established by the US Food and Drug Administration (FDA) that outlines the requirements for medical device manufacturers to establish and maintain a quality management system (QMS). The QSR applies to all medical devices sold in the United States, regardless of whether they are manufactured domestically or imported.
Looking for Consultant in Delhi?
Let’s have word about your project
This process typically involves a team of experts, including engineers, scientists, regulatory specialists, and quality assurance professionals, who work together to ensure that the medical device is safe, effective, and meets the needs of patients and healthcare providers.
How Operon Strategist can assist in FDA 21 CFR Part 820(QSR)
Role in FDA 21 CFR Part 820 – Quality System Regulations:
- Operon Strategist does an initial gap analysis of the existing system to determine the extent of development of the quality system.
- Provide 21 CFR 820 training courses in which we guide the clients through documentation & help them to effectively implement it through the various functions of the company.
- Conducted a mock audit to test the effectiveness of the implementation of Part 820 requirements.
- Provide post-inspection guidance to clients to help them close any non-conformance observed during the audit.
- FDA 21 CFR Part 820 helps manufacturers to build and follow quality systems to help assure that their products consistently meet applicable requirements and specifications.
FAQs
What is FDA 21 CFR Part 820?
FDA 21 CFR Part 820, also known as the Quality System Regulation (QSR), is a regulation issued by the U.S. Food and Drug Administration that establishes Quality Management System (QMS) requirements for medical device manufacturers marketing products in the United States.
Why is 21 CFR Part 820 compliance important for Delhi-based manufacturers?
Compliance ensures that medical devices meet US regulatory standards for safety and effectiveness, allowing Delhi-based manufacturers to legally sell their products in the United States and strengthen global market credibility.
What does 21 CFR Part 820 cover?
It includes requirements related to design controls, production and process controls, packaging, labeling, storage, installation, servicing, CAPA (Corrective and Preventive Actions), complaint handling, and proper documentation systems.
Is FDA 21 CFR Part 820 mandatory for exporting to the US?
Yes. All medical device manufacturers, whether located in India or abroad, must comply with 21 CFR Part 820 if they intend to market their devices in the United States.
How long does it take to implement FDA 21 CFR Part 820 compliance?
The timeline for implementing FDA 21 CFR Part 820 depends on the current maturity of the company’s Quality Management System (QMS). Typically, it may take a few months to fully develop documentation, implement processes, train employees, and prepare for inspection readiness in accordance with requirements set by the U.S. Food and Drug Administration.